These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19648165)

  • 1. Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.
    Peinemann F; Grouven U; Kröger N; Pittler M; Zschorlich B; Lange S
    Haematologica; 2009 Dec; 94(12):1732-42. PubMed ID: 19648165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.
    Peinemann F; Grouven U; Kröger N; Bartel C; Pittler MH; Lange S
    PLoS One; 2011 Apr; 6(4):e18572. PubMed ID: 21541024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
    Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J
    Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.
    Perez-Albuerne ED; Eapen M; Klein J; Gross TJ; Lipton JM; Baker KS; Woolfrey A; Kamani N
    Br J Haematol; 2008 Apr; 141(2):216-23. PubMed ID: 18307564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic transplantation for aplastic anemia.
    Eapen M
    Hematology; 2012 Apr; 17 Suppl 1():S15-7. PubMed ID: 22507769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
    Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
    Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
    JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.
    Bacigalupo A; Socié G; Hamladji RM; Aljurf M; Maschan A; Kyrcz-Krzemien S; Cybicka A; Sengelov H; Unal A; Beelen D; Locasciulli A; Dufour C; Passweg JR; Oneto R; Signori A; Marsh JC;
    Haematologica; 2015 May; 100(5):696-702. PubMed ID: 25616576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.
    Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z
    Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
    Deeg HJ; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski JL; Territo M; Ramsay N; Harris RE; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
    Biol Blood Marrow Transplant; 1999; 5(4):243-52. PubMed ID: 10465104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.
    Wagner JE; Rosenthal J; Sweetman R; Shu XO; Davies SM; Ramsay NK; McGlave PB; Sender L; Cairo MS
    Blood; 1996 Aug; 88(3):795-802. PubMed ID: 8704232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia].
    Chen HR; Lou JX; Zhang Y; Liu XD; Yang K; Chen P; Liu B; He XP; Guo Z; Liu D
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):959-64. PubMed ID: 22931664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.
    Kim H; Im HJ; Koh KN; Kang SH; Yoo JW; Choi ES; Cho YU; Jang S; Park CJ; Seo JJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):965-974. PubMed ID: 30639824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia.
    Rice C; Eikema DJ; Marsh JCW; Knol C; Hebert K; Putter H; Peterson E; Deeg HJ; Halkes S; Pidala J; Anderlini P; Tischer J; Kroger N; McDonald A; Antin JH; Schaap NP; Hallek M; Einsele H; Mathews V; Kapoor N; Boelens JJ; Mufti GJ; Potter V; Pefault de la Tour R; Eapen M; Dufour C
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):488-495. PubMed ID: 30194027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy and safety of co-transplantation of unrelated donor peripheral blood stem cells combined with umbilical mesenchymal stem cells in patients with refractory severe aplastic anemia-Ⅱ].
    Zhao MY; Fu YW; Wang Q; Ai H; Wang YQ; Li TT; Zhou J; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):819-822. PubMed ID: 31665857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.